Sensocure one of Financial Times 1000 fastest growing companies

We are proud to announce that Sensocure has earned position no. 482 in the 5th annual edition of the FT1000 Europe’s Fastest Growing Companies ranking. The rating is the result of a joint initiative by the Financial Times and Statista, which conducted months of research, public calls, intensive database research and directly contacted tens of thousands of companies. In the end, outstanding companies among millions of European enterprises were identified. Sensocure clearly stood out, and is now publicly recognised in the FT as one of Europe’s Fastest Growing Companies. The report stands as an acknowledgement by the Financial Times and Statista of Sensocure’s rapid, sustainable and predominantly organic growth. 

View the full publication here: https://www.ft.com/reports/europes-fastest-growing-companies

 

Long term license agreement

Sensocure AS, Horten and ExoStat Medical, Inc., Prior Lake, Minnesota, have made an agreement on a long-term technology license agreement relating to an electronic sensor that measures partial pressure COs (pCO2) in oral mucosal tissue. The sensor will constitute an essential component of a new non-invasive device developed to measure tissue hypoperfusion and the possible onset of sepsis (“blood poisoning”). Sepsis is a medical condition that claims millions of lives each year, represents enormous medical expense, and is presently the 10th most frequent cause of death in the U.S. The sensor is part of the MicroStat System and will be owned by ExoStat.

Exostat pressrelease in English

Sensocure pressrelease in Norwegian

New location

New location

On January 1st 2017 Sensocure moved into its new facilities at Skoppum. The facility is in a new building of approximately 1000 square meters constituting a new wing of Langmyra 11. Here we can continue developing our product in a 300 square meters’ cleanroom class 6,...

read more
The Nano2021 program

The Nano2021 program

17. Feb 2015: The Nano2021 program has allocated funding for six projects after the announcement of funds with deadline 15.10.2014. In total 54,8 million NOK was distributed. Sensocure was one of the six projects that reached up with a research project entitled...

read more
Pre-projects IscAlert™

Pre-projects IscAlert™

27. Jan 2014: Sensocure is about to start the main project for calibration and user interface for IscAlert™, funded by Oslofjordfondet. In collaboration with Oslo University Hospital, Buskerud and Vestfold University College, MicroTech Innovation, Eker Design and...

read more
Financed pre-projects

Financed pre-projects

24. Oct 2013: Since June 2013 Sensocure has been running two pre-projects financed by Oslofjordfondet on concepts for calibration and user interface for the IscAlert™ sensor.  Further research and development is being carried out to develop the concept. The results of...

read more

Sensocure AS

Sensocure AS develops biomedical
sensors for healthcare. The main product
under development is IscAlert™, a CO2
sensor designed for the earliest possible
detection of ischemia.

Press and public relations

Sensocure er Gasellebedrift

Sensocure er en av de 3484 norske bedrifter som kan kalle seg for Gaselle-bedrift 2019. For å komme på DNs gaselleliste, må bedriften de siste fire årene ha:- hatt omsetning over én million kroner- levert godkjente regnskaper-...

Sensocure blant Norges raskest voksende

Deloitte Norges Technology Fast 50 er en rangering av Norges 50 raskest voksende teknologiselskaper, basert på omsetningsvekst gjennom de siste fire årene. Vi er stolte av å være på den endelige listen over Fast 50 for 2019! Les mer om Fast 50

Sensocure har fått BIA-midler av Norges Forskningsråd

Gjennom BIA (Brukerstyrt innovasjonsarena) finansierer Norges Forskningsråd prosjekter som skal gi høy verdiskaping både for de deltagende bedriftene og for samfunnet. Sensocure var en av søkerne til høstens utlysning, og har nådd frem med sin søknad. Prosjektet...